This session will discuss the automation of all lab operations at the Genome Technology Access Center (GTAC@MGI) in the McDonnell Genome Institute at the Washington University School of Medicine. This work started with COVID-related workflow, which played a vital role in enabling rapid testing of large numbers of people. Speakers will also provide steps and insights to the overall digital transformation in a molecular diagnostic lab; insights including the scope, timing, flexibility, and agility of implementation, as well as results and key findings. The L7 Informatics’ Enterprise Science Platform (L7|ESP) gives diagnostic companies (including companion diagnostics, IVD, LDT) total visibility over all their operations while digitizing, integrating, and automating scientific, analytical, and operational workflows. L7|ESP will increase sample throughput and quality assurance in results and provide reliable documentation for regulatory review (CAP/CLIA/GLP/cGMP).

Attendees to this session will learn about:

• Digital transformation of COVID-19 testing procedures, including connecting testing processes with laboratory instruments and software systems and integrating data management and reporting.
• The benefits and need of digital transformation in molecular diagnostic labs.
• How to implement a composable enterprise framework to make digital transformation possible and offer organizations the ability to scale-up critical functions more rapidly without the re-tooling or redeveloping capabilities.

Find out more and register.